Pharmacy Investors (GRDN) sells 827,636 Guardian Pharmacy shares

Rhea-AI Filing Summary

Pharmacy Investors, LLC, a member of a 10% owner group of Guardian Pharmacy Services, Inc., sold 827,636 shares of Class A common stock in an open-market transaction on March 20, 2026 at an average price of $29.6825 per share. After this sale, Pharmacy Investors, LLC still directly holds 1,035,928 shares of Guardian’s Class A common stock. The shares were sold as part of an underwriting agreement involving the company and other selling stockholders.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pharmacy Investors, LLC

(Last) (First) (Middle)

401 PENNSYLVANIA PARKWAY, SUITE 115

(Street)

INDIANAPOLIS INDIANA 46280

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Guardian Pharmacy Services, Inc. [ GRDN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
			Member of 10% owner group

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	03/20/2026		S(1)		827,636	D	$29.6825	1,035,928	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of Class A common stock, par value $0.001 per share, of Guardian Pharmacy Services, Inc. (the "Issuer"), sold pursuant to the Underwriting Agreement, dated March 18, 2026, by and among the Issuer, the selling stockholders party thereto, and BofA Securities, Inc. and Jefferies LLC, as representatives of the several underwriters named therein.

	/s/ Douglas Towns, Attorney-in-Fact	03/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Pharmacy Investors, LLC do in this Guardian (GRDN) Form 4?

Pharmacy Investors, LLC reported selling 827,636 shares of Guardian Pharmacy Services Class A common stock. The transaction was an open-market sale executed on March 20, 2026, under an underwriting agreement with investment banks acting as underwriters.

What price did Pharmacy Investors, LLC receive for Guardian (GRDN) shares?

The shares were sold at an average price of $29.6825 per Guardian Pharmacy Services Class A common share. This price reflects the per-share consideration received in the open-market sale executed pursuant to the underwriting agreement.

How many Guardian (GRDN) shares does Pharmacy Investors, LLC still own?

After the reported sale, Pharmacy Investors, LLC directly holds 1,035,928 shares of Guardian Pharmacy Services Class A common stock. This remaining stake is disclosed as the total shares beneficially owned following the transaction.

Was the Guardian (GRDN) share sale linked to an underwriting agreement?

Yes. The footnote explains the 827,636 Guardian Pharmacy Services Class A shares were sold pursuant to an underwriting agreement dated March 18, 2026, involving the issuer, certain selling stockholders, and underwriters led by BofA Securities and Jefferies.

Who is the reporting person in this Guardian (GRDN) Form 4 filing?

The reporting person is Pharmacy Investors, LLC, described as a member of a 10% owner group of Guardian Pharmacy Services, Inc. It reported the sale as a direct ownership transaction in Class A common stock.